55 related articles for article (PubMed ID: 36504068)
1. Algae-mediated route to biogenic cuprous oxide nanoparticles and spindle-like CaCO
Taherzadeh Soureshjani P; Shadi A; Mohammadsaleh F
RSC Adv; 2021 Mar; 11(18):10599-10609. PubMed ID: 35423598
[TBL] [Abstract][Full Text] [Related]
2. [Cuprous oxide nanoparticles-based photothermal and chemodynamic synergistic therapy inhibits proliferation and migration of gastric cancer cells
Wen H; Huang X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1732-1738. PubMed ID: 36504068
[TBL] [Abstract][Full Text] [Related]
3. [Manganese-based nanoparticles for chemodynamic therapy of gastrointestinal cancer].
Lin X; Huang M; Chen J; Zhou X; Zhong Z; Lu W; Huang X; Liu T
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1432-1439. PubMed ID: 37712282
[TBL] [Abstract][Full Text] [Related]
4. [Natural melanin-based nanoparticles with photothermal/photodynamic activities induce ovarian cancer cell death].
Yang J; Chen X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1681-1688. PubMed ID: 36504061
[TBL] [Abstract][Full Text] [Related]
5. Infection microenvironment-activated nanoparticles for NIR-II photoacoustic imaging-guided photothermal/chemodynamic synergistic anti-infective therapy.
Yang N; Guo H; Cao C; Wang X; Song X; Wang W; Yang D; Xi L; Mou X; Dong X
Biomaterials; 2021 Aug; 275():120918. PubMed ID: 34058607
[TBL] [Abstract][Full Text] [Related]
6. Glutathione Depletion-Induced ROS/NO Generation for Cascade Breast Cancer Therapy and Enhanced Anti-Tumor Immune Response.
Wang J; Sang Y; Chen W; Cheng L; Du W; Zhang H; Zheng B; Song L; Hu Y; Ma X
Int J Nanomedicine; 2024; 19():2301-2315. PubMed ID: 38469056
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional Doxorubicin@Hollow-Cu
Liu X; Geng P; Yu N; Xie Z; Feng Y; Jiang Q; Li M; Song Y; Lian W; Chen Z
J Colloid Interface Sci; 2022 Jun; 615():38-49. PubMed ID: 35124505
[TBL] [Abstract][Full Text] [Related]
8. Cuprous oxide-based nanocrystals with combined chemo/chemodynamic therapy to increase tumor drug sensitivity by reducing mitochondria-derived adenosine-triphosphate.
He H; Wu J; Liang M; Xiao Y; Wei X; Cao Y; Chen Z; Lin T; Ye M
Drug Deliv; 2022 Dec; 29(1):3134-3141. PubMed ID: 36154354
[TBL] [Abstract][Full Text] [Related]
9. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer.
Ahmadi F; Sodagar-Taleghani A; Ebrahimnejad P; Pouya Hadipour Moghaddam S; Ebrahimnejad F; Asare-Addo K; Nokhodchi A
Int J Pharm; 2022 Sep; 625():122099. PubMed ID: 35961417
[TBL] [Abstract][Full Text] [Related]
10. An Overview of the Importance of Transition-Metal Nanoparticles in Cancer Research.
Szewczyk OK; Roszczenko P; Czarnomysy R; Bielawska A; Bielawski K
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743130
[TBL] [Abstract][Full Text] [Related]
11. Copper-based nanomaterials for cancer theranostics.
Zhong X; Dai X; Wang Y; Wang H; Qian H; Wang X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1797. PubMed ID: 35419993
[TBL] [Abstract][Full Text] [Related]
12. Surgical Management of Gastric Cancer: A Review.
Li GZ; Doherty GM; Wang J
JAMA Surg; 2022 May; 157(5):446-454. PubMed ID: 35319717
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
